全文获取类型
收费全文 | 45989篇 |
免费 | 5183篇 |
国内免费 | 1372篇 |
专业分类
耳鼻咽喉 | 78篇 |
儿科学 | 2873篇 |
妇产科学 | 414篇 |
基础医学 | 3911篇 |
口腔科学 | 250篇 |
临床医学 | 3918篇 |
内科学 | 6614篇 |
皮肤病学 | 353篇 |
神经病学 | 1048篇 |
特种医学 | 842篇 |
外国民族医学 | 1篇 |
外科学 | 12405篇 |
综合类 | 7032篇 |
现状与发展 | 4篇 |
一般理论 | 1篇 |
预防医学 | 2494篇 |
眼科学 | 289篇 |
药学 | 3068篇 |
21篇 | |
中国医学 | 6192篇 |
肿瘤学 | 736篇 |
出版年
2024年 | 96篇 |
2023年 | 1088篇 |
2022年 | 1372篇 |
2021年 | 2871篇 |
2020年 | 2415篇 |
2019年 | 2248篇 |
2018年 | 2061篇 |
2017年 | 2191篇 |
2016年 | 2182篇 |
2015年 | 2064篇 |
2014年 | 3388篇 |
2013年 | 3401篇 |
2012年 | 2478篇 |
2011年 | 2727篇 |
2010年 | 2189篇 |
2009年 | 1986篇 |
2008年 | 1922篇 |
2007年 | 1837篇 |
2006年 | 1712篇 |
2005年 | 1437篇 |
2004年 | 1282篇 |
2003年 | 1106篇 |
2002年 | 912篇 |
2001年 | 867篇 |
2000年 | 654篇 |
1999年 | 547篇 |
1998年 | 485篇 |
1997年 | 380篇 |
1996年 | 376篇 |
1995年 | 417篇 |
1994年 | 366篇 |
1993年 | 321篇 |
1992年 | 308篇 |
1991年 | 318篇 |
1990年 | 255篇 |
1989年 | 259篇 |
1988年 | 223篇 |
1987年 | 199篇 |
1986年 | 183篇 |
1985年 | 216篇 |
1984年 | 186篇 |
1983年 | 113篇 |
1982年 | 161篇 |
1981年 | 141篇 |
1980年 | 102篇 |
1979年 | 123篇 |
1978年 | 78篇 |
1977年 | 72篇 |
1976年 | 75篇 |
1975年 | 46篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
61.
Zehua Li Ji Wu Xiuli Zhang Caiwen Ou Xinglong Zhong Yanting Chen Lihe Lu Hailin Liu Yining Li Xiaoyu Liu Bo Wu Yuxi Wang Pingzhen Yang Jianyun Yan Minsheng Chen 《The Journal of pathology》2019,249(4):461-471
Vascular calcification is prevalent in patients with chronic kidney disease (CKD) and a major risk factor of cardiovascular disease. Vascular calcification is now recognised as a biological process similar to bone formation involving osteogenic differentiation of vascular smooth muscle cells (VSMCs). Cell division cycle 42 (CDC42), a Rac1 family member GTPase, is essential for cartilage development during endochondral bone formation. However, whether CDC42 affects osteogenic differentiation of VSMCs and vascular calcification remains unknown. In the present study, we observed a significant increase in the expression of CDC42 both in rat VSMCs and in calcified arteries during vascular calcification. Alizarin red staining and calcium content assay revealed that adenovirus-mediated CDC42 overexpression led to an apparent VSMC calcification in the presence of calcifying medium, accompanied with up-regulation of bone-related molecules including RUNX2 and BMP2. By contrast, inhibition of CDC42 by ML141 significantly blocked calcification of VSMCs in vitro and aortic rings ex vivo. Moreover, ML141 markedly attenuated vascular calcification in rats with CKD. Furthermore, pharmacological inhibition of AKT signal was shown to block CDC42-induced VSMC calcification. These findings demonstrate for the first time that CDC42 contributes to vascular calcification through a mechanism involving AKT signalling; this uncovered a new function of CDC42 in regulating vascular calcification. This may provide a potential therapeutic target for the treatment of vascular calcification in the context of CKD. © 2019 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd. 相似文献
62.
《Advances in medical sciences》2019,64(2):211-215
PurposeContrast-induced acute kidney injury (CI-AKI) is a common and potentially serious complication of percutaneous coronary interventions (PCI). In this study, we tested the hypothesis whether serum and urinary hepcidin could represent early biomarkers of CI-AKI in patients with normal serum creatinine undergoing PCI. In addition, we assessed serum and urinary neutrophil gelatinase-associated lipocalin (NGAL), cystatin C, eGFR and serum creatinine in these patients.MethodsSerum and urinary hepcidin and NGAL, serum cystatin C, were evaluated before, and after 2, 4, 8, 24 and 48 h after PCI using commercially available kits. Serum creatinine was assessed before, 24 and 48 h after PCI.ResultsWe found a significant rise in serum hepcidin as early as after 4 and 8 h when compared to the baseline values. Serum NGAL increased after 2, 4 and 8 h, and in urinary NGAL after 4, 8 and 24 h after PCI. We found a significant fall in urinary hepcidin after 8 and 24 h after PCI. Serum cystatin C increased significantly 8 h after PCI, reaching peak 24 h after PCI and then decreased after 48 h. The prevalence of CI-AKI was 8%. Urine hepcidin was significantly lower 8 and 24 h after PCI in patients with CI-AKI, while serum and urine NGAL were significantly higher in patients with CI-AKI.ConclusionsOur findings suggest that serum hepcidin might be an early predictive biomarker of ruling out CI-AKI after PCI, thereby contributing to early patient risk stratification. However, our data needs to be validated in large cohorts with various stages of CKD. 相似文献
63.
64.
65.
66.
67.
S.W. Considine N.F. Davis L.C. McLoughlin P. Mohan J.C. Forde R. Power G. Smyth D.M. Little 《The surgeon》2019,17(1):1-5
Introduction
Transplant units are exploring strategies to increase the availability of donor kidneys. The use of en-bloc kidney transplantation (EBKT) from paediatric donors represents one potential solution. We present our long-term experience with paediatric EBKT among adult recipients.Methods
Twenty-three paediatric to adult EBKTs were performed by the Irish National Kidney Transplant Service between 1990 and 2016. The primary outcome variable was long-term en-bloc allograft survival rate. Secondary outcome variables were incidence of allograft thrombosis, incidence of delayed graft function, overall patient survival and serum creatinine at most recent follow-up. Outcomes were compared to single kidney transplant recipients from the same time period.Results
Mean donor age was 1.8 ± 0.97 years (range: 7 months to 3 years). Recipient age was 46 ± 12 years. Mean follow-up was 133 ± 64 months (range: 36–264). Overall graft survival was 100%, 91% and 80% after 1, 5 and 10 years respectively, compared to 92%, 79% and 61% in single kidney transplant recipients (p = 0.04). There were 5 cases of allograft failure, 3 due to death from unrelated causes. Median time to graft failure was 108 months (range: 36–172). Mean serum creatinine was 72.6 ± 21.6 μmol/l after the follow-up period. There were no cases of graft thrombosis or delayed graft function. Overall survival was 96.4%, 88.0%, 76.23% and 50.5% at 1, 5, 10 and 20 years respectively.Conclusion
En-bloc paediatric kidney transplantation is associated with excellent long-term allograft and patient survival and is a feasible strategy for increasing the transplant donor pool in carefully selected recipients. 相似文献68.
69.
70.